References
- Ahsan H, Ahad A, Iqbal J, Siddiqui WA. 2014. Pharmacological potential of tocotrienols: a review. Nutr Met. 11:52.10.1186/1743-7075-11-52
- Ahsan H, Ahad A, Siddiqui WA. 2015. A review of characterization of tocotrienols from plant oils and foods. J Chem Biol. 8:45–59.10.1007/s12154-014-0127-8
- Bartosińska E, Buszewska-Forajta M, Siluk D. 2016. GC-MS and LC-MS approaches for determination of tocopherols and tocotrienols in biological and food matrices. J Pharm Biomed Anal. 127:156–169.10.1016/j.jpba.2016.02.051
- Couladouros EA, Moutsos VI, Lampropoulou M, Little JL, Hyatt JA. 2007. A short and convenient chemical route to optically pure 2-methyl chromanols. Total asymmetric synthesis of β-, γ-, and δ-tocotrienols. J Org Chem. 72:6735–6741.10.1021/jo0705418
- De Silva L, Chuah LH, Meganathan P, Fu JY. 2016. Tocotrienol and cancer metastasis. Biofactors. 42:149–162.
- Eitsuka T, Tatewaki N, Nishida H, Nakagawa K, Miyazawa T. 2016. Synergistic anticancer effect of tocotrienol combined with chemotherapeutic agents or dietary components: a review. Int J Mol Sci. 17:1605.10.3390/ijms17101605
- Frega N, Mozzon M, Bocci F. 1998. Identification and estimation of tocotrienols in the annatto lipid fraction by gas chromatography–mass spectrometry. J Am Oil Chem Soc. 75:1723–1727.10.1007/s11746-998-0323-1
- Galli F, Azzi A, Birringer M, Cook-Mills JM, Eggersdorfer M, Frank J, Cruciani G, Lorkowski S, Özer NK. 2016. Vitamin E: emerging aspects and new directions. Free Rad Biol Med. 102:16–36.
- Grimm MO, Mett J, Hartmann T. 2016. The impact of vitamin E and other fat-soluble vitamins on Alzheimer’s disease. Int J Mol Sci. 17:E1785.10.3390/ijms17111785
- Huang Y, Wu R, Su Z-Y, Gu Y, Zheng X, Yang CS, Kong A-N. 2016. A naturally occurring mixture of tocotrienols inhibits the growth of human prostate tumor, associated with epigenetic modifications of cyclin-dependent kinase inhibitors p21 and p27. J Nutr Biochem. 40:155–163.
- Kline K, Lawson KA, Yu W, Sanders BG. 2007. Vitamin E and cancer. Vit Horm. 76:435–461.10.1016/S0083-6729(07)76017-X
- Kua YL, Gan S, Morris A, Ng HK. 2016. A validated, rapid, simple and economical high-performance liquid-chromatography method to quantify palm tocopherol and tocotrienols. J Food Comp Anal. 53:22–29.10.1016/j.jfca.2016.09.003
- Mahipal A, Klapman J, Vignesh S, Yang CS, Neuger A, Chen DT, Malafa MP. 2016. Pharmacokinetics and safety of vitamin E δ-tocotrienol after single and multiple doses in healthy subjects with measurement of vitamin E metabolites. Cancer Chemother Pharmacol. 78:157–165.10.1007/s00280-016-3048-0
- Meganathan P, Fu JY. 2016. Biological properties of tocotrienols: evidence in human studies. Int J Mol Sci. 17:E1682.10.3390/ijms17111682
- Montagnani Marelli M, Marzagalli M, Moretti RM, Beretta G, Casati L, Comitato R, Gravina GL, Festuccia C, Limonta P. 2016. Vitamin E δ-tocotrienol triggers endoplasmic reticulum stress-mediated apoptosis in human melanoma cells. Sci Rep. 6:30502.10.1038/srep30502
- Peh HY, Tan WSD, Liao W, Wong WSF. 2016. Vitamin E therapy beyond cancer: tocopherol versus tocotrienol. Pharmacol Therap. 162:152–169.10.1016/j.pharmthera.2015.12.003
- Strohschein S, Rentel C, Lacker T, Bayer E, Albert K. 1999. Separation and identification of tocotrienol isomers by HPLC-MS and HPLC-NMR coupling. Anal Chem. 71:1780–1785.10.1021/ac981089i
- Torquato P, Ripa O, Giusepponi D, Galarini R, Bartolini D, Wallert M, Pellegrino R, Cruciani G, Lorkowski S, Birringer M, Mazzini F, Galli F. 2016. Analytical strategies to assess the functional metabolome of vitamin E. J Pharm Biomed Anal. 124:399–412.10.1016/j.jpba.2016.01.056
- Yano T, Sato A, Sekine M, Virgona N, Ota M. 2013. Redox-inactive analogue of tocotrienol as a potential anti-cancer agent. Anticancer Agents Med Chem. 13:496–501.